There are 400,000 people right
now on waiting lists for organs. [text on screen: 400,000 people worldwide are waiting for an organ]
What if you could make lungs, [text on screen: 20 people die each day. Waiting for a transplant]
livers, corneas?
What if we create a scalable
capability to do that?
It's unprecedented.
[text on screen: The Millyard, Manchester NH] This is about solving problems
that will impact every disease.
It's not regenerative medicine
that we're trying to create here.
It's the manufacturing of
replacement human organs.
[text on screen: A new challenge] The bridge really is between the
automation and the scientist.
To scale it from doing a few
things in a lab, to doing 10s
of thousands of tissues per year.
And that's what we're doing.
[text on screen: A new way to bring industries together] The idea was that we would gather
off the shelf technologies and
integrate them into a cohesive system
that we could do scalable, modular,
automated and closed manufacturing.
[text on screen: Scalable, modular, automated, closed, manufacturing] All the researchers need
a sterile environment.
They all need ways to move, measure,
control, but scaling it up if we can
solve it once and solve it right.
The modular capability applies
to all of them.
The automation line is going to help us
to develop consistent product that
we can test at the end in a high
throughput manner to understand what's
critical about that product in order
to ensure that the quality of product
is maintained all the way through.
And now we're sitting in a room
with the first complete system that
you put in a vial of cells at one
end and 45 days from today will
come a completely final product,
ready to implant,
and this system,
is nothing but Rockwell Automation
boxes tying all of this together.
[text on screen: Over 140 member companies] We talked about 140 companies being involved.
It is definitely about a team.
This is about teamwork
and it's about changing healthcare
and how we're going to go forward.
I used to give talks before we had the line.
I would always say I want to
manufacture a tissue in this room
and we've made that a reality.
We're trying to build
things that cure disease,
not just treat symptoms.
We're going to solve a healthcare problem,
which is the largest single problem,
both economically this country faces
and in terms of quality of life.